Please try another search
Cipla Quality Chemical Industries Limited, a pharmaceutical manufacturing company, manufactures and delivers anti-retroviral, anti-malarial, and hepatitis B medicines. The company offers Duovir-N; Lamivudine and Zidovudine; Efavir 60; Duomune; Nevirapine; Efavirenz, Lamivudine, and Tenofovir; and Dolutegravir, Lamivudine, and Tenofovir tablets for the treatment of HIV infection. It also offers Lumartem/Lumet tablets for the treatment of malaria; and Texavir and Zentair for the treatment of Hepatitis B. The company was formerly known as Quality Chemicals Industries Limited and changed its name to Cipla Quality Chemical Industries Limited in March 2014. The company was incorporated in 2005 and is based in Kampala, Uganda. Cipla Quality Chemical Industries Limited operates as a subsidiary of Cipla Limited.
Name | Age | Since | Title |
---|---|---|---|
Emmanuel Katongole | 59 | 2005 | Founder & Executive Chairman |
Ajay Kumar Pal | - | 2021 | CEO & Executive Director |
Zain Latiff | 39 | - | Alternate Director |
Geena V. Malhotra | - | 2019 | Non-Executive Director |
Stevens Mwanje | - | 2019 | Non-Executive Director |
James Paul Miller | 59 | - | Non-Executive Director |
Peter Mugyenyi | 75 | 2018 | Independent Non-Executive Director |
Mark Warwick Daly | 43 | 2018 | Non-Executive Director |
Joseph Baliddawa | 69 | 2018 | Independent Non-Executive Director |
George William Baguma | 63 | - | Executive Director of Commercial Affairs & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review